Skip to content
Accessibility help

Search NICE…

Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
BNF for Children (BNFC)
Life sciences
More from NICE

Search results

Skip to results

Area of interest

Area of interestAntimicrobial prescribing (38)COVID-19 (34)

Type

TypeGuidance (4868)Indicators (320)News (367)NICE advice (498)Quality standards (255)Research recommendations (1785)

Status

StatusAwaiting development (389)Deferred (2)Discontinued (350)In consultation (12)In development (375)Published (2588)Topic prioritisation (386)

Last updated

Last updatedLast 3 months (221)Last 6 months (371)Last year (713)Last 3 years (1445)

Guidance programme

Guidance programmeAntimicrobial prescribing guidelines (25)Antimicrobial resistance guidance (2)Cancer service guidelines (10)Clinical guidelines (387)COVID-19 rapid guidelines (27)Diagnostics guidance (87)Health technology evaluations (57)HealthTech guidance (796)Highly specialised technologies guidance (45)Interventional procedures guidance (990)Medical technologies guidance (143)Medicines practice guidelines (5)NICE guidelines (569)Public health guidelines (89)Safe staffing guidelines (4)Social care guidelines (47)Technology appraisal guidance (2239)

Advice programme

Advice programmeCOVID-19 rapid summaries (8)Evidence summaries (172)Medtech innovation briefings (324)NICE reviews (2)

Showing 2506 to 2520 of 8789 results

Sort by

Imbio CT lung texture analysis for identifying interstitial lung disease (MT618) (MIB272)
Topic prioritisation
Result type
Diagnostics guidance
Status
Topic prioritisation
Subcutaneous nivolumab for treating advanced renal cell carcinoma after systemic treatment TSID 12008
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Aflibercept for untreated retinopathy in babies born preterm TS ID 11943
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Letermovir for preventing cytomegalovirus infection in people under 18 years after allogeneic haematopoietic stem cell transplant [TS ID 11868]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Lenacapavir for treating multidrug resistant HIV-1 [ID6196]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
DV7103 for treating cystinuria in people 6 months and over [TSID10438]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Riluzole oral film for treating amyotrophic lateral sclerosis [TSID11779]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Emtricitabine/tenofovir alafenamide for human immunodeficiency virus type-1 infection [TSID10723]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Dupilumab for maintenance treatment of uncontrolled moderate to severe asthma in children 6 to 11 years [TSID10085]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Glucarpidase for reducing toxic plasma methotrexate levels in people aged 28 days and over [TSID10761]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Bardoxolone methyl for treating chronic kidney disease in people 12 years and over with Alport syndrome [TSID9998]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Subcutaneous belimumab for treating systemic lupus erythematosus in children aged 5 to 17 [TSID11828]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Avtozma (tocilizumab biosimilar) for treating moderate to severe rheumatoid arthritis in people aged 18 to 75 [TSID11848]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Dapsone for treating COVID-19 in people 40 years and over with high-risk comorbidity and people 70 years and over [TSID11892]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Ciclosporin ophthalmic solution for treating dry eyes after inadequate response to artificial tears [TSID8472]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation

Previous page
1
…
166
167
Current page 168
169
170
…
586
Page 168 of 586
Next page

Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS) Clinical Knowledge Summaries
British National Formulary (BNF) British National Formulary
BNF for Children (BNFC) British National Formulary for Children
Life sciences
Library and knowledge services

What NICE does
Implementing NICE guidance
Get involved
About us
Careers
News, blogs and podcasts
Newsletters and alerts
Contact us
Leave feedback
Reusing our content
NICE UK Open Content Licence
Syndicate our content
Events

Facebook
X
YouTube
LinkedIn

Accessibility
Freedom of information
Glossary
Terms and conditions
Privacy notice
Cookies

© NICE 2026. All rights reserved. Subject to Notice of rights.